22 Jun 2021 Janssen Pharmaceutica NV plant eerste Europese productiecentrum voor celtherapie in België Member news
22 Jun 2021 Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy Member news
17 Jun 2021 Biotalys’ ongoing trial program demonstrates strong potential of its new generation protein-based biocontrols Member news
17 Jun 2021 argenx announces publication of Phase 3 ADAPT trial results of efgartigimod for the treatment of generalized myasthenia gravis in The Lancet Neurology Member news
16 Jun 2021 Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd. Member news
15 Jun 2021 Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us